应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVRO Avrobio Inc.
盘前交易 12-23 05:11:07 EST
16.80
+0.00
0.00%
最高
16.80
最低
16.80
成交量
0.00
今开
16.80
昨收
16.80
日振幅
0.00%
总市值
7.54亿
流通市值
5.18亿
总股本
4,489万
成交额
28.97万
换手率
0.00%
流通股本
3,086万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Avrobio, Inc.盘中异动 股价大涨5.67%
自选股智能写手 · 05-25
Avrobio, Inc.盘中异动 股价大涨5.67%
Avrobio, Inc.盘中异动 早盘股价大跌5.19%
自选股智能写手 · 05-14
Avrobio, Inc.盘中异动 早盘股价大跌5.19%
AVROBIO Inc 预计每股亏损 36 美分 - 财报前瞻
Reuters · 05-07
AVROBIO Inc 预计每股亏损 36 美分 - 财报前瞻
Avrobio, Inc.盘中异动 股价大跌5.47%
自选股智能写手 · 03-25
Avrobio, Inc.盘中异动 股价大跌5.47%
AVROBIO Inc 预计每股亏损 36 美分 - 财报前瞻
Reuters · 03-19
AVROBIO Inc 预计每股亏损 36 美分 - 财报前瞻
Avrobio, Inc.盘中异动 股价大跌5.12%
自选股智能写手 · 03-16
Avrobio, Inc.盘中异动 股价大跌5.12%
Avrobio, Inc.盘中异动 急速跳水9.02%报1.21美元
自选股智能写手 · 03-05
Avrobio, Inc.盘中异动 急速跳水9.02%报1.21美元
Avrobio Inc盘中异动 临近午盘大幅下挫7.69%报1.20美元
自选股智能写手 · 02-14
Avrobio Inc盘中异动 临近午盘大幅下挫7.69%报1.20美元
Avrobio Inc盘中异动 快速上涨5.12%报1.21美元
自选股智能写手 · 01-31
Avrobio Inc盘中异动 快速上涨5.12%报1.21美元
BUZZ-Avrobio 与 Tectonic Therapeutic 合并后暴跌
Reuters · 01-31
BUZZ-Avrobio 与 Tectonic Therapeutic 合并后暴跌
Avrobio Inc股价重挫21.79% 市值跌1040.71万美元
自选股智能写手 · 01-30
Avrobio Inc股价重挫21.79% 市值跌1040.71万美元
Avrobio Inc盘中异动 早盘急速下挫6.38%报1.32美元
自选股智能写手 · 01-16
Avrobio Inc盘中异动 早盘急速下挫6.38%报1.32美元
Avrobio Inc盘中异动 临近午盘股价大跌5.52%报1.37美元
自选股智能写手 · 01-12
Avrobio Inc盘中异动 临近午盘股价大跌5.52%报1.37美元
Avrobio Inc盘中异动 早盘快速上涨5.56%报1.52美元
自选股智能写手 · 01-03
Avrobio Inc盘中异动 早盘快速上涨5.56%报1.52美元
Avrobio Inc盘中异动 快速上涨6.62%报1.45美元
自选股智能写手 · 01-02
Avrobio Inc盘中异动 快速上涨6.62%报1.45美元
公司概况
公司名称:
Avrobio Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
AVROBIO, Inc.是2015年11月根据特拉华州法律成立的一家公司。该公司是一家临床阶段基因治疗公司,专注于开发潜在治愈性的基于体外慢病毒的基因治疗,以单剂量治疗罕见疾病。该公司的基因疗法采用从患者中提取的造血干细胞,然后用慢病毒载体进行修饰,以插入在目标疾病中有缺陷的基因的功能性拷贝。
发行价格:
--
{"stockData":{"symbol":"AVRO","market":"US","secType":"STK","nameCN":"Avrobio Inc.","latestPrice":16.8,"timestamp":1718913600000,"preClose":16.8,"halted":8,"volume":0,"delay":0,"floatShares":30861934,"shares":44893750,"eps":0.674368,"marketStatus":"盘前交易","marketStatusCode":1,"change":0,"latestTime":"12-23 05:11:07 EST","open":16.8,"high":16.8,"low":16.8,"amount":289671.477312,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.674368,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"symbolChange":{"newSymbol":"TECX","executeDate":"2024-06-21"},"adr":0,"listingDate":1529553600000,"adjPreClose":16.8,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/AVRO/wiki","defaultTab":"wiki","newsList":[{"id":"2438068583","title":"Avrobio, Inc.盘中异动 股价大涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438068583","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438068583?lang=zh_cn&edition=full","pubTime":"2024-05-25 00:44","pubTimestamp":1716569061,"startTime":"0","endTime":"0","summary":"北京时间2024年05月25日00时44分,Avrobio, Inc.股票出现异动,股价大幅拉升5.67%。截至发稿,该股报1.49美元/股,成交量9.2326万股,换手率0.21%,振幅2.84%。Avrobio, Inc.股票所在的生物技术行业中,整体涨幅为0.99%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Merus N.V.涨幅较大,Onconetix, Inc.、Verastem, Inc.、Altamira Therapeutics Ltd.较为活跃,换手率分别为137.26%、52.94%、33.53%,振幅较大的相关个股有Onconetix, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cns Pharmaceuticals, Inc.,振幅分别为104.53%、57.38%、52.04%。Avrobio, Inc.公司简介:Avrobio Inc是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525004421af8a30d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525004421af8a30d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVRO"],"gpt_icon":0},{"id":"2435851677","title":"Avrobio, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435851677","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435851677?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:34","pubTimestamp":1715693652,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时34分,Avrobio, Inc.股票出现异动,股价快速跳水5.19%。截至发稿,该股报1.28美元/股,成交量1.1269万股,换手率0.03%,振幅2.96%。Avrobio, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Nutriband Inc C/Wts 、Generation Bio Co.、Taysha Gene Therapies, Inc.涨幅较大,Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Scorpius Holdings, Inc.较为活跃,换手率分别为38.87%、8.38%、7.33%,振幅较大的相关个股有Transcode Therapeutics, Inc.、Absci Corporation、Fennec Pharmaceuticals Inc.,振幅分别为21.54%、16.99%、13.77%。Avrobio, Inc.公司简介:Avrobio Inc是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421341279279e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421341279279e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVRO","BK4139"],"gpt_icon":0},{"id":"2433207319","title":"AVROBIO Inc 预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433207319","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433207319?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:24","pubTimestamp":1715088277,"startTime":"0","endTime":"0","summary":" * AVROBIO Inc 预计将于5月9日公布截至2024年3月31日的财报(预计) * * LSEG分析师对AVROBIO公司的平均预期是每股亏损36美分。* 目前,分析师对该公司股票的平均评级为 \"买入\",建议分类为 1 个 \"强烈买入 \"或 \"买入\",1 个 \"持有\",没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 AVROBIO 公司 12 个月目标价的中位数为 2.00 美元,高于上一次收盘价 1.24 美元。5月7日 - 本摘要于北京时间5月7日13:24由机器生成。除非另有说明,所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVRO"],"gpt_icon":0},{"id":"2422517472","title":"Avrobio, Inc.盘中异动 股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422517472","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422517472?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:30","pubTimestamp":1711373424,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时30分,Avrobio, Inc.股票出现波动,股价快速下挫5.47%。截至发稿,该股报1.21美元/股,成交量2848股,换手率0.01%,振幅0.00%。Avrobio, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.涨幅较大,Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为582.19%、46.17%、30.45%,振幅较大的相关个股有Cara Therapeutics, Inc.、Clene Inc.、Kazia Therapeutics Limited,振幅分别为7.03%、4.62%、3.71%。Avrobio, Inc.公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325213024861e0d93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325213024861e0d93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVRO","BK4139"],"gpt_icon":0},{"id":"2420422190","title":"AVROBIO Inc 预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2420422190","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420422190?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:11","pubTimestamp":1710853885,"startTime":"0","endTime":"0","summary":" * AVROBIO Inc 预计将于3月21日公布截至2024年3月31日的财报(预计) * * LSEG分析师对AVROBIO公司的平均预期是每股亏损36美分。* 目前,分析师对该公司股票的平均评级为 \"买入\",建议分类为 1 个 \"强烈买入 \"或 \"买入\",1 个 \"持有\",没有 \"卖出 \"或 \"强烈卖出\"。* 在过去三个月中,分析师的平均盈利预期上升了约 12.6%。* 华尔街对 AVROBIO 公司 12 个月目标价的中位数为 2.00 美元,高于其上次收盘价 1.29 美元。3月19日 - 本摘要于北京时间 3 月 19 日 13:11 编辑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVRO"],"gpt_icon":0},{"id":"2419348183","title":"Avrobio, Inc.盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419348183","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419348183?lang=zh_cn&edition=full","pubTime":"2024-03-16 01:21","pubTimestamp":1710523293,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日01时21分,Avrobio, Inc.股票出现波动,股价快速跳水5.12%。截至发稿,该股报1.21美元/股,成交量34.3312万股,换手率0.77%,振幅6.69%。Avrobio, Inc.股票所在的生物技术行业中,整体跌幅为0.42%。其相关个股中,杰龙、Better Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃,换手率分别为331.71%、79.56%、30.15%,振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、联拓生物,振幅分别为114.29%、63.00%、49.00%。Avrobio, Inc.公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160121337a4d1a6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160121337a4d1a6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVRO"],"gpt_icon":0},{"id":"2417179875","title":"Avrobio, Inc.盘中异动 急速跳水9.02%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417179875","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417179875?lang=zh_cn&edition=full","pubTime":"2024-03-05 03:34","pubTimestamp":1709580872,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日03时34分,Avrobio, Inc.股票出现异动,股价快速跳水9.02%。截至发稿,该股报1.21美元/股,成交量4.3518万股,换手率0.10%,振幅3.38%。Avrobio, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Avrobio, Inc.公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030503343287e75bb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030503343287e75bb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","BK4139","AVRO"],"gpt_icon":0},{"id":"2411364537","title":"Avrobio Inc盘中异动 临近午盘大幅下挫7.69%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411364537","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2411364537?lang=zh_cn&edition=full","pubTime":"2024-02-14 00:32","pubTimestamp":1707841976,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日00时32分,Avrobio Inc股票出现波动,股价快速下跌7.69%。截至发稿,该股报1.20美元/股,成交量16.3125万股,换手率0.37%,振幅5.00%。Avrobio Inc股票所在的生物技术行业中,整体跌幅为0.40%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm Plc C/Wts 10/02/2028 、Candel Therapeutics Inc涨幅较大,Biodexa Pharmaceuticals Plc、Revelation Biosciences Inc、Adial Pharmaceuticals Inc较为活跃,换手率分别为413.51%、134.41%、126.42%,振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Calidi Biotherapeutics Inc、Renovaro Biosciences Inc,振幅分别为53.85%、50.00%、44.72%。Avrobio Inc公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021400325687e6fef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021400325687e6fef3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVRO","BK4139"],"gpt_icon":0},{"id":"2408557659","title":"Avrobio Inc盘中异动 快速上涨5.12%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408557659","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2408557659?lang=zh_cn&edition=full","pubTime":"2024-01-31 23:39","pubTimestamp":1706715594,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日23时39分,Avrobio Inc股票出现波动,股价快速拉升5.12%。截至发稿,该股报1.21美元/股,成交量42.8037万股,换手率0.96%,振幅4.35%。Avrobio Inc股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,2Seventy Bio Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Vaxart Inc涨幅较大,Revelation Biosciences Inc、Ensysce Biosciences Inc、Neximmune Inc较为活跃,换手率分别为703.87%、483.97%、311.21%,振幅较大的相关个股有Neximmune Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Revelation Biosciences Inc,振幅分别为66.53%、49.63%、48.43%。Avrobio Inc公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131233954790de422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131233954790de422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVRO"],"gpt_icon":0},{"id":"2407628483","title":"BUZZ-Avrobio 与 Tectonic Therapeutic 合并后暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2407628483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2407628483?lang=zh_cn&edition=full","pubTime":"2024-01-31 00:36","pubTimestamp":1706632607,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 1月30日 - ** 基因疗法开发商Avrobio 股价下跌20.1%至1.09美元,为7月以来最低价** 该公司称 (link) 它将收购 Tectonic Therapeutic 100%的股权 ** 预计合并后的公司在交易完成时将拥有约1.65亿美元的现金和现金等价物 ** AVRO 称 Tectonic 已从生命科学投资者处获得 1.307 亿美元的私募融资承诺** 截至上次收盘,股价在过去 12 个月中上涨了 24.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVRO","BK4139","BUZZ"],"gpt_icon":0},{"id":"2407505533","title":"Avrobio Inc股价重挫21.79% 市值跌1040.71万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407505533","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2407505533?lang=zh_cn&edition=full","pubTime":"2024-01-30 22:32","pubTimestamp":1706625126,"startTime":"0","endTime":"0","summary":"北京时间2024年01月30日22时32分,Avrobio Inc股票出现异动,股价大幅下挫21.79%。截至发稿,该股报1.07美元/股,成交量39.6205万股,换手率0.89%,振幅9.49%。Avrobio Inc股票所在的生物技术行业中,整体跌幅为0.25%。其相关个股中,Iterum Therapeutics Plc、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大,Iterum Therapeutics Plc、Panbela Therapeutics Inc、Novabay Pharmaceuticals Inc较为活跃,换手率分别为104.04%、91.47%、50.72%,振幅较大的相关个股有Psyence Biomedical Ltd、Gri Bio Inc、Fibrogen Inc,振幅分别为800.00%、18.89%、10.60%。Avrobio Inc公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240130223206815b68d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240130223206815b68d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVRO","BK4139"],"gpt_icon":0},{"id":"2403893585","title":"Avrobio Inc盘中异动 早盘急速下挫6.38%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2403893585","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2403893585?lang=zh_cn&edition=full","pubTime":"2024-01-16 22:49","pubTimestamp":1705416569,"startTime":"0","endTime":"0","summary":"北京时间2024年01月16日22时49分,Avrobio Inc股票出现异动,股价快速下挫6.38%。截至发稿,该股报1.32美元/股,成交量1.5225万股,换手率0.03%,振幅2.82%。Avrobio Inc股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Elevai Labs Inc、Celularity Inc C/Wts 16/07/2026 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Elevai Labs Inc、Atreca Inc、Kintara Therapeutics Inc较为活跃,换手率分别为105.06%、11.81%、10.24%,振幅较大的相关个股有Moolec Science Sa C/Wts 、Elevai Labs Inc、Revolution Medicines Inc C/Wts ,振幅分别为43.57%、40.94%、30.97%。Avrobio Inc公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240116224929861caaa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240116224929861caaa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVRO","BK4139"],"gpt_icon":0},{"id":"2402408664","title":"Avrobio Inc盘中异动 临近午盘股价大跌5.52%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402408664","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2402408664?lang=zh_cn&edition=full","pubTime":"2024-01-12 00:35","pubTimestamp":1704990918,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日00时35分,Avrobio Inc股票出现波动,股价急速跳水5.52%。截至发稿,该股报1.37美元/股,成交量5.3532万股,换手率0.12%,振幅4.14%。Avrobio Inc股票所在的生物技术行业中,整体跌幅为0.71%。其相关个股中,Atreca Inc、Surrozen Inc C/Wts 01/08/2031 、Moolec Science Sa涨幅较大,Atreca Inc、Clearmind Medicine Inc、Neximmune Inc较为活跃,换手率分别为399.68%、285.74%、60.93%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Atreca Inc、Moolec Science Sa C/Wts ,振幅分别为71.43%、59.29%、47.00%。Avrobio Inc公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112003518790827a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112003518790827a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVRO","BK4139"],"gpt_icon":0},{"id":"2400087606","title":"Avrobio Inc盘中异动 早盘快速上涨5.56%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2400087606","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2400087606?lang=zh_cn&edition=full","pubTime":"2024-01-03 23:25","pubTimestamp":1704295558,"startTime":"0","endTime":"0","summary":"北京时间2024年01月03日23时25分,Avrobio Inc股票出现异动,股价快速拉升5.56%。截至发稿,该股报1.52美元/股,成交量8.0126万股,换手率0.18%,振幅4.86%。Avrobio Inc股票所在的生物技术行业中,整体涨幅为0.24%。其相关个股中,Neximmune Inc、Jasper Therapeutics Inc C/Wts 24/09/2026 、Abvc Biopharma Inc涨幅较大,Neximmune Inc、First Wave Biopharma Inc、Abvc Biopharma Inc较为活跃,换手率分别为2964.59%、763.62%、535.01%,振幅较大的相关个股有Neximmune Inc、Jasper Therapeutics Inc C/Wts 24/09/2026 、Celularity Inc C/Wts 16/07/2026 ,振幅分别为149.89%、72.14%、65.80%。Avrobio Inc公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240103232559861c83bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240103232559861c83bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVRO"],"gpt_icon":0},{"id":"2400927866","title":"Avrobio Inc盘中异动 快速上涨6.62%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2400927866","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2400927866?lang=zh_cn&edition=full","pubTime":"2024-01-02 22:59","pubTimestamp":1704207564,"startTime":"0","endTime":"0","summary":"北京时间2024年01月02日22时59分,Avrobio Inc股票出现波动,股价快速拉升6.62%。截至发稿,该股报1.45美元/股,成交量2.3111万股,换手率0.05%,振幅1.95%。Avrobio Inc股票所在的生物技术行业中,整体涨幅为1.04%。其相关个股中,Longboard Pharmaceuticals Inc、Zura Bio Limited C/Wts 20/03/2028 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Soligenix Inc、Kintara Therapeutics Inc、Aditxt Inc较为活跃,换手率分别为364.59%、201.64%、54.73%,振幅较大的相关个股有Longboard Pharmaceuticals Inc、Soligenix Inc、Cardio Diagnostics Holdings Inc,振幅分别为73.80%、31.70%、23.69%。Avrobio Inc公司简介:Avrobio公司是一家处于临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401022259247905a21a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401022259247905a21a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVRO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avrobio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.0448},{"period":"ytd","weight":0.0294}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AVROBIO, Inc.是2015年11月根据特拉华州法律成立的一家公司。该公司是一家临床阶段基因治疗公司,专注于开发潜在治愈性的基于体外慢病毒的基因治疗,以单剂量治疗罕见疾病。该公司的基因疗法采用从患者中提取的造血干细胞,然后用慢病毒载体进行修饰,以插入在目标疾病中有缺陷的基因的功能性拷贝。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.073131},{"month":2,"riseRate":0.5,"avgChangeRate":0.053252},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.019148},{"month":4,"riseRate":0,"avgChangeRate":-0.128692},{"month":5,"riseRate":0.666667,"avgChangeRate":0.08204},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.040606},{"month":7,"riseRate":0.5,"avgChangeRate":0.140951},{"month":8,"riseRate":0.5,"avgChangeRate":-0.009617},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.081011},{"month":10,"riseRate":0.833333,"avgChangeRate":-0.032791},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.031753},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.048984}],"exchange":"NASDAQ","name":"Avrobio Inc.","nameEN":"Avrobio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avrobio Inc.(AVRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Avrobio Inc.(AVRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Avrobio Inc.,AVRO,Avrobio Inc.股票,Avrobio Inc.股票老虎,Avrobio Inc.股票老虎国际,Avrobio Inc.行情,Avrobio Inc.股票行情,Avrobio Inc.股价,Avrobio Inc.股市,Avrobio Inc.股票价格,Avrobio Inc.股票交易,Avrobio Inc.股票购买,Avrobio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avrobio Inc.(AVRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Avrobio Inc.(AVRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}